Example: Heart Attack

Clinical Trials on Hypertrophy, Left Ventricular

Total 167 results

NCT05942729

Recruiting

Etiological DiagnOsis of caRdiac Diseases Based on echoCardiograpHIc Images and Clinical Data. (ORCHID)

Cardiomyopathies | Left Ventricular Hypertrophy | Hypertension Arterial | Hypokinetic
NCT05903313

Not yet recruiting

A Study to Evaluate Accuracy and Validity of the Chang Gung ECG Abnormality Detection Software

Myocardial Infarction | Left Bundle-Branch Block | Atrial Flutter | Left Ventricular Hypertrophy | Long QT Syndrome | Sinus Bradycardia | Right Bundle-Branch Block | Sinus Tachycardia | Premature Atrial Complexes | Premature Ventricular Complexes
NCT05841654

Not yet recruiting

Effect of Azilsartan on Atrial Fibrillation in Patients With Hypertension (AZAF)

Hypertension | Atrial Fibrillation
NCT05730309

Not yet recruiting

Point-of-care Ultrasound and Treatment Disparities for Left Ventricular Hypertrophy

Left Ventricular Hypertrophy
NCT05719337

Recruiting

Multi-Modality Echocardiographic Techniques in Pathological Left Ventricular Hypertrophy Adults (MET-LVH)

Left Ventricular Hypertrophy
NCT05646056

Recruiting

A Noninterventional, Single-Center Feasibility Study to Evaluate Measures of Heart Failure Risk

Heart Failure | Cardiomyopathy, Hypertrophic | Left Ventricular Hypertrophy
NCT05593055

Recruiting

Mineralocorticoid Receptor, Coronary Microvascular Function, and Cardiac Efficiency in Hypertension

Hypertension | Left Ventricular Hypertrophy
NCT05524077

Recruiting

Catheter Ablation Versus Anti-arrhythmic Drugs for Ventricular Tachycardia (CAAD-VT)

Ventricular Tachycardia | Cardiomyopathy, Dilated | Heart Disease Structural Disorder | Sarcoidosis | Cardiomyopathy, Hypertrophic | Cardiomyopathy, Familial | Cardiomyopathy Ischemic | Arrhythmogenic Right Ventricular Cardiomyopathy 1 | Arrhythmogenic Left Ventricular Cardiomyopathy
NCT05435898

Not yet recruiting

Assessment and Digital-health Based Intervention on Subclinical Organ Damage and Cardiovascular Risk in Chinese

Cardiovascular Diseases | Cardiovascular Morbidity | Digital Health | Subclinical Organ Damage
NCT05388032

Recruiting

Sodium Lowering Vascular Effects Trial (SOLVE)

Endothelial Dysfunction | Vascular Stiffness | Left Ventricular Dysfunction | Left Ventricular Hypertrophy
NCT05280548

Recruiting

A Study to Evaluate the Effect of Venglustat Tablets on Left Ventricular Mass Index in Male and Female Adult Participants With Fabry Disease (CARAT)

Fabry Disease
NCT05241431

Recruiting

Effect of Dapagliflozin on Myocardial and Renal Function Following Aortic Valve Stenosis Intervention (DAPAS)

Aortic Stenosis | Left Ventricle Hypertrophied
NCT05179668

Recruiting

SGLT2 Inhibition in Hemodialysis (DAPA-HD)

Diabetes Mellitus, Type 2 | Hemodialysis | Chronic Kidney Disease | Kidney Failure | Left Ventricular Hypertrophy
NCT05002010

Not yet recruiting

Left Ventricular Hypertrophy Among Chronic Kidney Disease Patients in Assiut University Hospital

Chronic Kidney Diseases | Left Ventricular Hypertrophy
NCT04929600

Recruiting

Sacubitril/Valsartan Versus Amlodipine in Hypertension and Left Ventricular Hypertrophy.

Hypertension | Left Ventricular Hypertrophy
NCT04916522

Recruiting

The COlchicine HypERtENsion Trial (COHERENT)

Hypertension
NCT04862273

Recruiting

Native T1 CMR Imaging for Diagnosis of Cardiac Amyloidosis (CMR for CA)

Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure With Preserved Ejection Fraction | Hypertrophy, Left Ventricular | Heart Failure NYHA Class IV | Cardiac Amyloidosis | Heart Failure With Mid Range Ejection Fraction
NCT04752293

Recruiting

Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE) (PHRASE)

Kidney Diseases | Hypertension | Pediatric Obesity | Proteinuria | Albuminuria | Kidney Injury | Blood Pressure Disorders | Autonomic Dysfunction | Pediatric Kidney Disease | Left Ventricular Dysfunction
NCT04644094

Recruiting

Postnatal Steroids Effects on Cardiac Function in Extremely Preterm (SPEC)

Left Ventricular Hypertrophy
NCT04471389

Not yet recruiting

Longitudinal Follow-up Study in Two Chinese Hypertension Cohorts

Hypertension
NCT04426578

Recruiting

Role of Perhexiline in Hypertrophic Cardiomyopathy (RESOLVE-HCM)

Hypertrophic Cardiomyopathy
NCT04265040

Recruiting

DZHK TORCH-Plus is a Registry for Patients With Cardiomyopathies and Serves as Source for Cardiovascular Research Studies (TORCH-Plus)

Amyloidosis | HCM - Hypertrophic Cardiomyopathy | Arrhythmogenic Right Ventricular Cardiomyopathy | Inflammatory Cardiomyopathy | DCM - Dilated Cardiomyopathy | Non-ischemic Cardiomyopathy | HOCM - Hypertrophic Obstructive Cardiomyopathy | Left Ventricular Noncompaction Cardiomyopathy
NCT04230551

Recruiting

Reverse Remodeling After PTSMA in Severe But Asymptomatic LVOT Obstruction (RASTA)

HOCM, Hypertrophic Obstructive Cardiomyopathy | LVOTO - Left Ventricular Outflow Tract Obstruction | Remodeling, Ventricular
NCT04022330

Not yet recruiting

Protective Monocytes and Macrophages to Limit Decompensation and Heart Damaging (PROMOMA)

Left Ventricular Hypertrophy
NCT03928158

Recruiting

LCZ696 in Advanced LV Hypertrophy and HFpEF

Heart Failure | Essential Hypertension
NCT03816462

Recruiting

ReNEW Clinic Cohort Study (ReNEW)

Hypertension | Obesity | Overweight | Prehypertension | Elevated Blood Pressure | Left Ventricular Hypertrophy
NCT03549559

Recruiting

Imaging Histone Deacetylase in the Heart

Diabetes | Aortic Valve Stenosis | Heart Failure With Normal Ejection Fraction | Left Ventricular Hypertrophy
NCT03542526

Recruiting

Relationship of Different Electrocardiographic Parameters and Ambulatory Blood Pressure Parameters to Detect Left Ventricular Hypertrophy

Hypertension
NCT03088514

Recruiting

Investigation of Dietary Nitrate Effects in Hypertension-induced Target Organ Damage (NITRATE-TOD)

Hypertension
NCT02973633

Recruiting

Diffusion MRI in Heart Failure

Myocardial Infarction | Heart Failure | Left Ventricular Hypertrophy
NCT02670031

Recruiting

Response of the Myocardium to Hypertrophic Conditions in the Adult Population

Myocardial Fibrosis | Hypertension | Left Ventricular Hypertrophy
NCT02432092

Recruiting

Pediatric Cardiomyopathy Mutation Analysis

Cardiomyopathies | Dilated Cardiomyopathy | Hypertrophic Cardiomyopathy | Arrhythmogenic Right Ventricular Cardiomyopathy | Restrictive Cardiomyopathy | Left Ventricular Non-compaction Cardiomyopathy
NCT04417829

Completed

Transcatheter Aortic Valve Implantation in Western NORway (TAVI-NOR)

Hypertension | Aortic Stenosis
NCT01638156

Completed

Cardiac MRI for Severe Aortic Stenosis

Aortic Stenosis
NCT03310684

Active, not recruiting

Pediatric Primary Hypertension and the Renin-Angiotensin System (PHRAS) (PHRAS)

Pediatric Obesity | Pediatric Disorder | Primary Hypertension
NCT03749551

Completed

Towards Understanding the Phenotype of Cardiovascular Disease in CKD - TRUE-Type-CKD Study (TRUE-TypeCKD)

Heart Failure | Chronic Kidney Diseases | Cardiomyopathies | Hypertrophy, Left Ventricular
NCT02611258

Completed

Endocrine Cardiomyopathy in Cushing Syndrome: Response to Cyclic GMP PDE5 inhibitOrs (ERGO)

Cushing's Syndrome Cardiomyopathy
NCT02611336

Completed

Endocrine Cardiomyopathy: Response to Cyclic GMP PDE5 Inhibitors in Acromegaly Cardiomyopathy (SUM)

Acromegaly Cardiomyopathy
NCT05713916

Enrolling by invitation

Effect of a Targeted Notification and Clinical Support Pathway on Individuals With Left Ventricular Hypertrophy (NOTIFY-LVH)

Hypertension | Cardiomyopathies | Hypertrophy, Left Ventricular
NCT03315832

Withdrawn

Efficacy of Angiotensin Receptor Blocker Following aortIc Valve Intervention for Aortic STenOsis: a Randomized mulTi-cEntric Double-blind Phase II Study (ARISTOTE)

Aortic Valve Stenosis | Transcatheter Aortic Valve Replacement | Hypertrophy, Left Ventricular | Angiotensin Receptor Antagonists | Heart Valve Prosthesis Implantation | Valsartan
NCT04461041

Completed

Empagliflozin and Cardiac Remodelling in People Without Diabetes (EMPA-HEART 2)

Cardiovascular Diseases | Left Ventricular Hypertrophy
NCT05726695

Active, not recruiting

The Use of Blood Biochemical Markers for Diagnostics of Heart Muscle Diseases

Heart Failure | Left Ventricular Hypertrophy | Heart Dilation
NCT03094143

Active, not recruiting

Early Valve Replacement Guided by Biomarkers of LV Decompensation in Asymptomatic Patients With Severe AS (EVoLVeD)

Aortic Valve Stenosis | Hypertrophy, Left Ventricular
NCT03842163

Completed

Prevalence and Characteristics of Transthyretin Amyloidosis in Patients With Left Ventricular Hypertrophy of Unknown Etiology (TTRACK)

Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)
NCT03300427

Completed

The Effects of Sacubitril/Valsartan on Cardiac Oxygen Consumption and Efficiency of Cardiac Work in Heart Failure Patients (TurkuPET)

Heart Failure
NCT03666351

Completed

Study to Evaluate the Effect on Improvement of LVH by the Control of BP in Hypertension Patients With AV Disease

Hypertension | Aortic Stenosis | Aortic Regurgitation | Left Ventricular Hypertrophy | LVM
NCT03489993

Completed

FGF23 and Angiotensin-(1-7) in Hypophosphatemia (GAP) (GAP)

Hypophosphatemia | X-linked Hypophosphatemia | Left Ventricular Hypertrophy | Renin-angiotensin System
NCT05373732

Completed

Stress Reduction in the Prevention of Left Ventricular Hypertrophy

High Blood Pressure | Left Ventricular Hypertrophy
NCT04275882

Completed

Demographical and Clinical Profile of Patients With Left Ventricular Hypertrophy

Left Ventricular Hypertrophy
NCT00338260

Completed

Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study (0954-133)

Hypertension and Left Ventricular Hypertrophy (Thickening of the Main Pumping Chamber of the Heart)

Clinical Trials on Hypertrophy, Left Ventricular

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cote d'Ivoire

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations